Discounted Cash Flow Rating

Buy

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Buy

Price to Earnings Rating

Buy

Analyst Rating

Neutral

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Strong Buy

Standard Deviation

Sell

Williams %R

Strong Buy

Average Directional Index

Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Neutral

B

IN8bio, Inc. Common Stock (INAB)

Biological Products, (no Disgnostic Substances)

https://www.in8bio.com

IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell product candidates for solid and liquid tumors, by employing allogeneic, autologous and genetically modified gamma-delta T cells.

EMPIRE STATE BUILDING, 350 5TH AVENUE, SUITE 5330
NEW YORK, NY

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

07/30/2021

Market Cap

31,277,043

Shares Outstanding

43,290,000

Weighted SO

43,287,325

Total Employees

N/A

Upcoming Earnings

08/08/2024

Similar Tickers

RVPH --.--%

CUE --.--%

LTRN --.--%

GRCL --.--%

ANIX --.--%

INMB --.--%

PYPD --.--%

ZURA --.--%

ANNX --.--%

Beta

0.0600

Last Div

0.0000

Range

0.59-2.48

Chg

0.0656

Avg Vol

385154

Mkt Cap

31277043

Exch

NASDAQ

Country

US

Phone

646 600 6438

DCF Diff

0.0812

DCF

0.5488

Div Yield

0.0000

P/S

8.3450

EV Multiple

-0.8764

P/FV

2.2147

Div Yield %

0.0000

P/E

-0.9440

PEG

-0.0399

Payout

0.0000

Current Ratio

2.6648

Quick Ratio

2.6648

Cash Ratio

2.1469

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

207.7493

CCC

-207.7493

Gross Margin

0.3231

Op Margin

-8.5427

Pretax Margin

-8.5267

Net Margin

-8.5267

Eff Tax Rate

0.2778

ROA

-1.4206

ROE

-1.7312

ROCE

-1.8052

NI/EBT

1.0000

EBT/EBIT

0.9981

EBIT/Rev

-8.5427

Debt Ratio

0.2622

D/E

0.4330

LT Debt/Cap

0.2321

Total Debt/Cap

0.3022

Int Coverage

-54.2678

CF/Debt

-4.1663

Equity Multi

1.6516

Rec Turnover

0.0000

Pay Turnover

1.7569

Inv Turnover

0.0000

FA Turnover

0.4058

Asset Turnover

0.1666

OCF/Share

-0.5445

FCF/Share

-0.5513

Cash/Share

0.2264

OCF/Sales

-6.5563

FCF/OCF

1.0123

CF Coverage

-4.1663

ST Coverage

-13.7896

CapEx Coverage

-81.0990

Div&CapEx Cov

-81.0990

P/BV

2.2147

P/B

2.2147

P/S

8.3450

P/E

-0.9440

P/FCF

-1.2573

P/OCF

-1.2276

P/CF

-1.2276

PEG

-0.0399

P/S

8.3450

EV Multiple

-0.8764

P/FV

2.2147

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Nov 02, 09:17 IN8bio to Present New Positive Data from Phase 1 Trial of INB-100 at 2023 American Society of Hematology (ASH) Annual Meeting

Revenue Product Segmentation